M5T-24492-34325
2 vaccinations
3 coded responses
17 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 977 / OR
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
-
2021-01-05
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Abdominal painAdult check-in
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to workAdult check-in
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
-
2021-01-12
Health check-in — day 7, dose 1Feeling: Fair · Site: Redness, Swelling, Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-19
Survey response — day 14, dose 1MedDRA: Injection site rash — Feeling: GoodFree text: Rash on injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
-
2021-02-02
Dose 2 — Moderna
- 2021-02-21
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
-
2021-05-04
Survey response — 3 months, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-05
Survey response — 6 months, dose 2MedDRA: Asthma, Dyspnoea, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Shortness of breath and asthma ExacerbationMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-05
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-09
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-02 | Moderna |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 14, dose 1
Symptoms: Rash on injection site
Release 8 — 3 months, dose 2
Symptoms: Fatigue
Release 9 — 6 months, dose 2
Symptoms: Shortness of breath and asthma Exacerbation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release